An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to argenx
Related studies linked through entity extraction aliases.
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
- Status
- COMPLETED
- Phase
- PHASE2
A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ARGX-110 in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2